SAN DIEGO, June 12, 2013 /PRNewswire/ --Sequenom, Inc. (SQNM), a life sciences company providing innovative genetic analysis solutions, today announced that its wholly owned subsidiary, the Sequenom Center for Molecular Medicine (Sequenom CMM), has completed the build-out and validation of an additional laboratory location in Raleigh-Durham, NC, and is now processing patient samples commercially. This new laboratory location adds capacity and redundancy to the existing Sequenom CMM laboratory locations in California and Michigan. With an initial capacity of 100,000 tests per year, the North Carolina facility will primarily support processing of the MaterniT21 PLUS laboratory-developed test (LDT) and will immediately increase Sequenom CMM's total MaterniT21 PLUS testing capacity to over 300,000 test samples per year. This practice-changing prenatal LDT analyzes the relative amount of chromosome 21, 18, and 13, as well as X and Y material in cell-free fetal DNA obtained from a maternal blood sample as early as 10 weeks ofpregnancy. "We are excited about the opening in North Carolina of our third US-based laboratory location. Our investment in establishing this new presence on the East coast will allow us to better meet the needs of health care providers by providing critical additional capacity and geographic back-up needed to … Continue reading →

Public release date: 11-Jun-2013 [ | E-mail | Share ] Contact: Deirdre Branley sciencenews@einstein.yu.edu 718-430-3101 Albert Einstein College of Medicine June 11, 2013 (BRONX, NY) Today, researchers at Albert Einstein College of Medicine of Yeshiva University convened a one-day conference on Jewish genetics designed to encourage collaboration and advance the field of research. Such research could help scientists identify causes and potential treatments for population-specific diseases as well as more common disorders afflicting the general population. The genetic makeup of Ashkenazi Jews is relatively homogenous, which makes it easier to identify gene variations that cause disease. By bringing together scientists who investigate Jewish genetics with those at disease-specific research centers, the conference organizers hope to encourage new, productive research partnerships that could uncover the causes of debilitating conditions. Twenty researchers from ten institutions are participating. From diabetes and arthritis to intellectual disabilities and Alzheimer's disease, a range of disorders are represented. Scientists studying Jewish genetics as well as those working with Latino/Hispanic, Amish and other racial and ethnic groups will also attend. "We would like to see new research centers or other large-scale, multi-investigator studies established that can mine Jewish genomic data for clues to disease," said Harry Ostrer, M.D., … Continue reading →

How much does the therapy cost? Visit http://www.clairerich-therapy.co.uk for more information. CALL (01245) 444105 NOW and let us help you find the way to a Richer Life! By: Claire Rich Therapy TV … Continue reading →

Stem cells treatment for avascular necrosis (AVN) in India Stem cell treatment treatment of AVN in India can cure early AVN. AVN is a condition that affects young patients. Often the cause is unknown. It invariably p... By: ALAMPALLAM VENKATACHALAM … Continue reading →

Horse therapy 2 By: myers2574 … Continue reading →

Carlsbad-based Life Technologies has introduced a test to help stem cell scientists quickly determine whether the cells theyre working with are any good. The test, which can help researchers save time and effort, uses objective measurements to create a score card of the cells characteristics. Its intended for use with human embryonic stem cells and induced pluripotent stem cells, which act much like embryonic stem cells. Life Technologies introduced the test, called the TaqMan hPSC Scorecard Panel, Wednesday at the International Society for Stem Cell Research conference in Boston. The test costs $700. Pluripotent stem cells are extremely versatile, capable of becoming almost any cell in the body. Both embryonic and IPS cells, made from skin cells reprogrammed to an embryonic-like state, have this power. But cells grown in lab cultures typically contain a mixture of truly pluripotent cells and others defective in some way. For example, cells may have a bias toward becoming a certain cell type. Stem cells can be used for disease in a dish models that shed light on disease processes, to test the effectiveness and toxicity of potential drugs, and for direct therapy by converting them into cells to replace diseased or injured tissues. However, … Continue reading →

BOCA RATON, FL--(Marketwired - Jun 11, 2013) - At Stem Cell Orthopedics, Medical Director Dr. Joseph Purita and his staff, are focused on utilizing the latest practices in regenerative medicine to offer innovative procedures to patients suffering from a wide range of injuries and degenerative conditions. Specifically, Dr. Purita and the other board-certified orthopedic surgeons at Stem Cell Orthopedics concentrate on the progressive use of platelet rich plasma (PRP) injection and stem cell therapies. Although Purita has already gained increasing recognition for his revolutionary use of regenerative medicine, he is encouraged by the continuing progress found within the medical community. As such, Dr. Joseph Purita highlights a recent study emerging from scientific researchers at the University of Pennsylvania focused in a new report from Science Daily. The article explains, "Bioengineers are interested in finding innovative ways to grow new cartilage from a patient's own stem cells, and, thanks to a new study from the University of Pennsylvania, such a treatment is a step closer to reality." Directed under the guidance of associated professor Jason Burdick, the research took a closer examination of how stem cells may improve and resolve the natural deterioration of cartilage experienced through aging, or sports injuries. … Continue reading →

Stem cells, the precursors to other kinds of cells in the human body, promise near-miracle medical treatments such as regenerating organs or repairing nerves. But stem cell medicine is still in the early stages. Culturing the right kind of cell remains difficult and so far only a few procedures are FDA-approved. Odds are it will be several years before a wide range of ailments can be treated with stem cells. For those who want to be ready for that day, some companies in the United States are offering people a chance to bank their stem cells for future use. That way when treatments are available, there will be stem cells ready to go that came from the patient's own body, eliminating the issue of rejection of donor cells. Meanwhile, the cells are presumably healthier, as they would have been collected from a younger, disease-free patient. "With all these amazing advancements in the last few years, there will be will be stem cell therapies," said Vin Singh, founder and CEO of Grand Forks, N.D.-based Next Healthcare, which offers stem cell banking. Next Healthcare is not the only bank out there. Other consumer stem cell banks which differ from the banks used … Continue reading →

The vision of nanomedicine in Israel Lecturer: Dr. Silvia Noiman "Medical Nanosystems New Solutions to Stubborn Challenges", Tel Aviv University Board of Governors 2013, 6.6.13. By: TAUVOD … Continue reading →